-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$6.75150% Upside
Nuvation Bio Inc. Frequently Asked Questions
-
What analysts cover Nuvation Bio Inc.?
Nuvation Bio Inc. has been rated by research analysts at H.C. Wainwright, RBC Capital, Jefferies, BTIG in the past 90 days.